Comparative Serum Proteomic Analysis of Serum Diagnosis Proteins of Colorectal Cancer Based on Magnetic Bead Separation and MALDI-TOF Mass Spectrometry |
Deng, Bao-Guo
(Department of Microbiology, Xinxiang Medical University)
Yao, Jin-Hua (Paediatrics Intensive Care Unit, the First Affiliated Hospital of Xinxiang Medical University) Liu, Qing-Yin (The Clinical Laboratory, No.150 Central Hospital of PLA) Feng, Xian-Jun (Department of Respiratory Medicine, the First Affiliated Hospital of Xinxiang Medical University) Liu, Dong (Department of Dermatology, the First Affiliated Hospital of Xinxiang Medical University) Zhao, Li (Paediatrics Intensive Care Unit, the First Affiliated Hospital of Xinxiang Medical University) Tu, Bin (Import-Export Inspection and Quarantine Bureau of Luoyang) Yang, Fan (Department of Microbiology, Xinxiang Medical University) |
1 | Cadeco S, Williamson AJ, Whetton AD (2012). The use of proteomics for systematic analysis of normal and transformed hematopoietic stem cells. Curr Pharm Des, 18, 1730-50. DOI |
2 | Alagaratnam S, Mertens BJ, Dalebout JC, et al (2008). Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics, 8, 1552-63. DOI ScienceOn |
3 | Baumann S, Ceglarek U, Fiedler GM, et al (2005). Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem, 51, 973-80. DOI ScienceOn |
4 | Boja ES, Rodriguez H (2012). Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins. Proteomics, 12, 1093-110. DOI ScienceOn |
5 | Chinello C, Gianazza E, Zoppis I, et al (2010). Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology, 75, 842-47. DOI ScienceOn |
6 | Cho WC (2007). Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer, 6, 25. DOI ScienceOn |
7 | Fan NJ, Gao CF, Wang XL (2011). Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterol Res Pract, 2011, 784967. |
8 | Garay JP, Gray JW (2012). Omics and therapy - a basis for precision medicine. Mol Oncol, 6, 128-39. DOI ScienceOn |
9 | Fan NJ, Gao CF, Zhao G, Wang XL, Qiao L (2012). Serum peptidome patterns for early screening of esophageal squamous cell carcinoma. Biotechnol Appl Biochem, 59, 276-82. DOI ScienceOn |
10 | Fan NJ, Gao CF, Zhao G, Wang XL, Liu QY (2012).Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol, 7, 45. DOI |
11 | Gemoll T, Roblick UJ, Auer G, Jornvall H, Habermann JK (2010).SELDI-TOF serum proteomics and colorectal cancer: a current overview. Arch Physiol Biochem, 116, 188-96. DOI ScienceOn |
12 | Heckman-Stoddard BM (2012). Oncology biomarkers: discovery, validation, and clinical use. Semin Oncol Nurs, 28, 93-8. DOI ScienceOn |
13 | Huang YJ, Xuan C, Zhang BB, et al (2009). SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res, 28, 85. DOI ScienceOn |
14 | Hudler P, Gorsic M, Komel R (2010). Proteomic strategies and challenges in tumor metastasis research. Clin Exp Metastasis, 27, 441-51. DOI |
15 | Issaq HJ, Xiao Z, Veenstra TD (2007): Serum and plasma proteomics. Chem Rev, 107, 3601-20. DOI ScienceOn |
16 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
17 | Compton CC, Greene FL (2004). The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin, 54, 295-308. DOI ScienceOn |
18 | Dai Y, Hu C, Wang L, et al (2010). Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. Scand J Rheumatol, 39, 240-6. DOI ScienceOn |
19 | Cho WC (2007). Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer, 6, 1. |
20 | Ciccolallo L, Capocaccia R, Coleman MP, et al (2005). Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut, 54, 268-73. DOI ScienceOn |
21 | Du J, Yang S, Lin X, et al (2010). Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagn Pathol, 5, 60. DOI ScienceOn |
22 | Edwards BK, Ward E, Kohler BA, et al (2010). Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 116, 544-73. DOI ScienceOn |
23 | Engwegen JY, Depla AC, Smits ME, et al (2008). Detection of colorectal cancer by serum and tissue protein profiling: a prospective study in a population at risk. Biomark Insights, 3, 375-85. |
24 | Fan NJ, Gao CF, Wang CS, et al (2012). Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach. Can J Gastroentero, 26, 41-7. |
25 | Pang J, Liu WP, Liu XP, et al (2010).Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res, 9, 216-26. DOI ScienceOn |
26 | Pan C, He N, Zhao M, et al (2011). Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Med Oncol, 28, 1349-55. DOI ScienceOn |
27 | Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W (2005). Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques, Suppl, 37-40. |
28 | Liu LH, Shan BE, Tian ZQ, et al (2010). Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem Lab Med, 48, 855-61. |
29 | Shin S, Cazares L, Schneider H, et al (2007). Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg, 204, 1065-71; discussion 1071-3. DOI ScienceOn |
30 | Smith RA, Cokkinides V, Brooks D, et al (2011). Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin , 61, 8-30. DOI |
31 | Wang Q, Shen J, Li ZF, et al (2009).Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer. BMC Cancer, 9, 287. DOI ScienceOn |
32 | West-Norager M, Kelstrup CD, Schou C, et al (2007). Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci, 847, 30-7. DOI ScienceOn |
33 | Fan NJ, Gao CF, Wang CS, et al (2012).Identification of the up-regulation of TP-alpha, collagen alpha-1 (VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. J Proteomics, 75, 3977-86. DOI ScienceOn |
34 | Cheng AJ, Chen LC, Chien KY, et al (2005). Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem, 51, 2236-44. DOI ScienceOn |
35 | Jemal A, Siegel R, Xu J, Ward E (2010).Cancer statistics2010. CA Cancer J Clin, 60, 277-300. DOI |
36 | Tolson JP, Flad T, Gnau V, et al (2006). Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics, 6, 697-708. DOI ScienceOn |
37 | Whiteaker JR, Zhao L, Zhang HY, et al (2007). Antibody-based enrichment of peptides on magnetic beads for massspectrometry-based quantification of serum biomarkers. Anal Biochem, 362, 44-54. DOI ScienceOn |
38 | Yao N, Chen H, Lin H, Deng C, Zhang X (2008). Enrichment of peptides in serum by C (8)-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. J Chromatogr A, 1185, 93-101. DOI ScienceOn |
39 | Zethelius B, Berglund L, Sundstrom J, et al (2008).Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med, 358, 2107-16. DOI ScienceOn |
![]() |